Kelin Li

发表

Figure 14, General synthetic route for preparing probe compound SID 103904185 (CID 49830260) and associated analogues

Patrick Porubsky, Jeffrey Aubé, Frank Schoenen, 2013 .

Table 6, Probe ML240 and analog submissions to MLSMR (BioFocus DPI) for reversible inhibitors of p97

Patrick Porubsky, Jeffrey Aubé, Frank Schoenen, 2013 .

Table D1, Description of the outcome for the screen of 827 compounds from the NCI DTP compound collection

Brian S. J. Blagg, Frank Schoenen, Jeffrey Aubé, 2013 .

Figure 3, General synthetic route for preparing probe compound SID 114279600 (CID 50930730) and associated analogues

Brian S. J. Blagg, Frank Schoenen, Jeffrey Aubé, 2013 .

Table 3, List of Assays and AIDs for this Project

Brian S. J. Blagg, Jill Ferguson, Jeffrey Aubé, 2013 .

Sequential Pd(II)-Pd(0) catalysis for the rapid synthesis of coumarins.

Kelin Li, Benjamin Neuenswander, Kelin Li, 2005, The Journal of organic chemistry.

Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.

Akbar Ali, Kelin Li, Alicia M. Hanson, 2015, ACS chemical biology.

Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline.

Jeffrey Aubé, Kelin Li, Alicia M. Hanson, 2012, Journal of medicinal chemistry.

Selective, reversible inhibitors of the AAA ATPase p97

Patrick Porubsky, Jeffrey Aubé, Kevin J. Frankowski, 2013 .